NSE ANURAS · BSE 543275 · Chemical Manufacturing · NIFTY 500
Anupam Rasayan India Share Price
Anupam Rasayan India Overview
Where the price stands, how it has moved and how it sits against its averages.
Anupam Rasayan India shares last traded at ₹1,181.40 on the NSE, down 1.19% on the day. That is 16.5% below the 52-week high of ₹1,415.40 and 12.8% above the 52-week low of ₹1,047.40. The stock trades at 76.80× earnings, above the sector average of 20.26. Its market value is ₹13,419 Cr.
Price returns
Against the market: 1 Month ▼ −2.53% · 3 Months ▼ −4.15% · 6 Months ▼ −5.25% · This year ▲ +3.05% · 1 Year ▲ +19.78%
Shading grows with the size of the move. We ask our data provider for a newer price every 15 minutes while the market is open (9:15 AM–3:30 PM IST); next check from Fri 16 Oct, 9:15 AM. Its quotes are not real-time — the time at the top shows how current the price is.
Moving averages — price is above 0 of 6
- 300-day average₹1,276.76 ▼ price 7.5% below
- 100-day average₹1,271.41 ▼ price 7.1% below
- 50-day average₹1,228.83 ▼ price 3.9% below
- 20-day average₹1,226.89 ▼ price 3.7% below
- 10-day average₹1,200.99 ▼ price 1.6% below
- 5-day average₹1,185.20 ▼ price 0.3% below
- Today's price₹1,181.40
Each average is the mean closing price over that many trading days; averages above the current price sit higher on the ladder.
Anupam Rasayan India Financial Results
Revenue and net profit in ₹ crore, with the full statements underneath.
Year by year
| Fiscal year | Revenue | Growth | Net profit | Net margin | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2026 | ₹2,365 Cr | ▲ +64.6% | ₹170 Cr | 7.2% | ₹15.09 | ₹1.50 |
| FY 2025 | ₹1,437 Cr | ▼ −2.6% | ₹93 Cr | 6.5% | ₹8.50 | ₹0.75 |
| FY 2024 | ₹1,475 Cr | ▼ −7.9% | ₹129 Cr | 8.7% | ₹11.87 | ₹1.25 |
| FY 2023 | ₹1,602 Cr | ▲ +50.3% | ₹181 Cr | 11.3% | ₹17.40 | ₹2.50 |
| FY 2022 | ₹1,066 Cr | ▲ +31.5% | ₹152 Cr | 14.3% | ₹15.18 | ₹1.50 |
| FY 2021 | ₹811 Cr | ▲ +53.3% | ₹70 Cr | 8.7% | ₹8.56 | ₹0.50 |
| FY 2020 | ₹529 Cr | — | ₹53 Cr | 10.0% | ₹5.30 | — |
Quarter by quarter
| Quarter | Revenue | vs prev. qtr | Net profit | Net margin | EPS |
|---|---|---|---|---|---|
| Q1 FY27 | ₹655 Cr | ▲ +3.0% | ₹39 Cr | 5.9% | ₹3.39 |
| Q4 FY26 | ₹636 Cr | ▲ +24.1% | ₹43 Cr | 6.7% | ₹3.75 |
| Q3 FY26 | ₹512 Cr | ▼ −29.9% | ₹49 Cr | 9.6% | ₹4.31 |
| Q2 FY26 | ₹731 Cr | ▲ +50.5% | ₹44 Cr | 6.1% | ₹3.93 |
| Q1 FY26 | ₹486 Cr | ▼ −2.6% | ₹34 Cr | 7.0% | ₹3.10 |
| Q4 FY25 | ₹499 Cr | ▲ +27.8% | ₹45 Cr | 8.9% | ₹4.06 |
| Q3 FY25 | ₹390 Cr | ▲ +32.7% | ₹28 Cr | 7.2% | ₹2.57 |
| Q2 FY25 | ₹294 Cr | — | ₹17 Cr | 5.7% | ₹1.51 |
Balance sheet — FY26
- Total assets₹8,013 Cr
- Total liabilities₹4,711 Cr
- Shareholders' equity₹3,302 Cr
- Total debt₹1,867 Cr
- Cash & investments₹403 Cr
- Current ratio1.43×
- Revenue growth, 5 yr23.88% a year
- EPS growth, 5 yr12.02% a year
- Operating margin (TTM)15.69%
- Net margin (TTM)8.88%
Cash flow — FY26
Right of the line = cash coming in, left = cash going out. Free cash flow = cash from operations minus capital spending.
Full financial statements, FY20–FY26
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Total revenue | 528.88 | 810.89 | 1,066.00 | 1,601.91 | 1,475.07 | 1,436.97 | 2,365.46 |
| Cost of revenue | 340.84 | 541.82 | 658.07 | 999.08 | 911.21 | 850.85 | 1,602.01 |
| Gross profit | 188.04 | 269.07 | 407.93 | 602.82 | 563.86 | 586.12 | 763.44 |
| Operating expenses | 422.70 | 668.78 | 828.96 | 1,241.39 | 1,173.47 | 1,137.56 | 1,965.00 |
| Operating income | 106.18 | 142.11 | 237.05 | 360.52 | 301.60 | 299.42 | 400.45 |
| Depreciation | 28.71 | 51.65 | 60.12 | 71.08 | 79.70 | 102.28 | 139.90 |
| Profit before tax | 71.37 | 100.00 | 221.86 | 307.66 | 241.77 | 197.85 | 254.40 |
| Tax | 18.40 | 29.71 | 69.68 | 90.82 | 74.34 | 37.88 | 32.21 |
| Net profit | 52.98 | 70.30 | 152.18 | 180.85 | 128.60 | 93.35 | 170.12 |
| EPS (₹) | 5.30 | 8.56 | 15.18 | 17.40 | 11.87 | 8.50 | 15.09 |
| Dividend per share (₹) | — | 0.50 | 1.50 | 2.50 | 1.25 | 0.75 | 1.50 |
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Total assets | 1,664.07 | 2,298.00 | 2,890.55 | 3,777.92 | 4,601.67 | 5,268.88 | 8,012.60 |
| Current assets | 551.53 | 1,114.65 | 1,446.63 | 2,111.19 | 2,226.62 | 2,573.04 | 3,727.51 |
| Cash & short-term investments | 26.83 | 255.71 | 209.71 | 629.92 | 349.83 | 128.24 | 403.32 |
| Inventory | 297.04 | 492.22 | 863.19 | 931.47 | 1,055.32 | 1,451.50 | 1,774.75 |
| Property, plant & equipment | 1,065.50 | 1,146.70 | 1,234.43 | 1,400.00 | 1,966.15 | 2,254.53 | 3,094.49 |
| Total liabilities | 1,070.35 | 724.60 | 1,163.70 | 1,405.33 | 1,840.64 | 2,418.57 | 4,710.77 |
| Current liabilities | 493.98 | 420.60 | 595.07 | 810.79 | 1,316.17 | 1,808.21 | 2,615.44 |
| Total debt | 855.30 | 423.13 | 836.21 | 821.71 | 1,069.06 | 1,373.38 | 1,867.49 |
| Total equity | 593.72 | 1,573.40 | 1,726.85 | 2,372.59 | 2,761.02 | 2,850.31 | 3,301.84 |
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| From operations | 94.94 | 1.46 | −171.23 | 292.07 | 59.03 | −30.13 | 334.33 |
| From investing | −178.20 | −193.08 | −412.04 | −522.66 | −392.11 | −329.91 | −820.24 |
| From financing | 101.43 | 415.77 | 384.36 | 370.65 | 395.07 | 223.27 | 620.93 |
| Capital expenditure | −180.39 | −146.02 | −146.86 | −220.77 | −715.99 | −409.92 | −555.16 |
| Dividends paid | — | — | −9.99 | −24.56 | −26.31 | −13.42 | −15.20 |
| Net change in cash | 18.17 | 224.15 | −198.91 | 140.06 | 61.99 | −136.76 | 135.02 |
Anupam Rasayan India vs Peers
Side by side with other chemical manufacturing companies. The small bars compare each column.
| Company | Price | Change | Market cap | P/E | P/B | ROE (5 yr) | Net margin | Div. yield |
|---|---|---|---|---|---|---|---|---|
| Anupam Rasayan India This stock | ₹1,181.40 | ▼ −1.19% | ₹13,419 Cr | 76.80 | 4.07 | 5.97% | 8.88% | 0.13% |
| Asian Paints | ₹2,398.85 | ▼ −2.21% | ₹2,30,097 Cr | 58.09 | 12.06 | 24.22% | 12.35% | 1.02% |
| Solar Industries India | ₹19,594.45 | ▼ −0.64% | ₹1,77,310 Cr | 99.61 | 26.62 | 30.43% | 17.65% | 0.06% |
| Pidilite Industries | ₹1,529.85 | ▼ −3.54% | ₹1,55,720 Cr | 64.76 | 14.71 | 21.84% | 16.92% | 0.73% |
| SRF | ₹2,528.85 | ▼ −0.44% | ₹74,961 Cr | 44.57 | 6.07 | 15.85% | 11.62% | 0.31% |
| Linde India | ₹6,196.20 | ▼ −1.46% | ₹52,844 Cr | 110.53 | 14.22 | — | 21.69% | 0.06% |
Peer prices and ratios as last reported by the data provider. Company names link to their own pages.
Anupam Rasayan India Key Metrics
Each ratio placed against a benchmark — the sector average, the company's own 5-year average, or a common rule of thumb.
Valuation The price against earnings, book value and sales
Profitability Of every ₹100 of sales, how much is kept?
Returns & efficiency How well does it use its money?
Growth Is the business getting bigger?
Financial strength Can it pay its bills and debts?
Per share What each share stands for
The share price is 4.07× the book value behind each share.
Benchmarks: sector averages and 5-year averages come from the data provider; the debt and liquidity bands are common rules of thumb, not investment advice.
All 107 metrics from the data provider
Valuation
Per share
Margins
Growth
Financial strength
Returns & efficiency
Price & volume
Dividends & Corporate Events
Payouts to shareholders, splits and bonus issues, and company meetings — newest first.
- Dividend yield0.13%
- Payout ratio9.94%
- 5-year average dividend₹1.50 a share
- Latest dividend₹1.50 per share · 18 Sep 2026
Corporate calendar
- MeetingAnnual General Meeting
- BoardTo approve fund raising of NCD's
- Dividend₹1.50 per share · 15% · Final dividend
- BoardQuarterly Results
- BoardAudited Results & Final Dividend
- MeetingPostal Ballot
- BoardQuarterly Results
- MeetingPostal Ballot
Show 14 older events
- MeetingPostal Ballot
- BoardQuarterly Results
- MeetingAnnual General Meeting
- BoardQuarterly Results
- Dividend₹0.75 per share · 8% · Interim dividend
- BoardInterim Dividend & Preferential issue
- BoardAudited Results
- MeetingPostal Ballot
- Dividend₹0.75 per share · 8% · Final dividend
- Dividend₹0.50 per share · 5% · Interim dividend
- Dividend₹1.50 per share · 15% · Interim dividend
- Dividend₹0.60 per share · 6% · Interim dividend
- Dividend₹1.00 per share · 10% · Final dividend
- Dividend₹0.40 per share · 4% · Interim dividend
About Anupam Rasayan India
Chemical Manufacturing
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Key people
- Gopal Puranmal AgarwalChief Executive Officer
- Mona Anandbhai DesaiVice Chairman of the Board and Whole-Time Director
- Amit KhuranaChief Financial Officer
- Ashish GuptaCompany Secretary and Compliance Officer
- Anand S. DesaiManaging Director, Executive Director
- Anuj Hemantbhai ThakarWhole-time Director
Company facts
- NSE symbolANURAS
- BSE code543275
- ISININE930P01018
- IndustryChemical Manufacturing
- IndexNIFTY 500
- Market cap₹13,419 Cr
- Revenue (FY26)₹2,365 Cr
- Net profit (FY26)₹170 Cr
In the News
Recent headlines about Anupam Rasayan India — they open on Mint in a new tab.
- Dividend stocks alert, record date: Last chance to buy Cochin Shipyard, Anupam Rasayan, Balu Forge, and others | List
Cochin Shipyard and others are likely to attract investors' attention on September 17 due to approaching dividend record dates.
17 Sep 2026 · 5 min read · Mint ↗ - Centre plans bulk drug PLI scheme revamp, says pharmaceuticals secretary Manoj Joshi
India's reliance on imports for certain critical classes of drugs creates strategic vulnerabilities by exposing the pharmaceutical supply chain to external disruptions and geopolitical risks.
28 Jul 2026 · 3 min read · Mint ↗
Stock data comes from the exchange feed via our data provider. It is not real-time and can be delayed, so check the price with your broker before you trade. This page is for information and education only. It is not investment advice, research or a recommendation to buy, sell or hold any security. Investments in the securities market are subject to market risks; read all related documents carefully before investing. See all stocks →